Dapagliflozin is a highly selective renal sodium-glucose co-transporter 2 (SGLT2) inhibitor [6] that lowers blood glucose in a dose-dependent, insulin-independent manner [7].
Dapagliflozin is a highly selective renal sodium-glucoseco-transporter 2 (SGLT2) inhibitor [6] that lowers blood glucosein a dose-dependent, insulin-independent manner [7].